Fundamental Data for LCI

LANNETT IN(AMEX:LCI)

Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.

# Employees: 187

Address: 9000 State Road,Philadelphia,PA,USA

Phone: 215 333-9000

Fax: 215 333-9004

Website: www.lannett.com

Email: investors@lannett.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

William Farber (Chmn.)

Ronald A. West (Vice-Chmn.; Dir.)

Arthur P. Bedrosian (Presi.; C.E.O.)

Brian J. Kearns (V.P.; Fin.; C.F.O.; Treas.)

Jeffrey Farber (Interim Chmn.; Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/10/2010

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Shares Performance

Period	LCI	Compare to S&P
YTD	28.00 %	5.94 %
4 Weeks	-9.86 %	-10.83 %
12 Weeks	-30.13 %	-34.13 %

Shares Information

Analyst Coverage: N

Avg Volume: 48180

Shares Outstanding: 24M

Market Cap: $0.16B

52 Week High: $9.67

52 Week Low: $1.79

P/E Ratio: 20.000

PEG Ratio: -0.010

Split: On 4/21/1992 LCI split by factor of 4.000

Earnings Performance

EPS Growth in Last Quarter: 10.00 %

EPS Growth in Last Year: 120.00 %

Sales Growth in Last Quarter: -11.32 %

Sales Growth in Last Quarter: 22.95 %

Financials

Qtr Book Value: $1.93

Cash Flow/Share: $13.50

Change in Payout Ratio: -0.010

Price/Sales: 1.250